Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells

J Immunol. 2002 Dec 1;169(11):6594-603. doi: 10.4049/jimmunol.169.11.6594.

Abstract

Chronic lymphocytic leukemia (CLL) results from the expansion of malignant CD5(+) B cells that usually express IgD and IgM. These leukemic cells can give rise in vivo to clonally related IgG(+) or IgA(+) elements. The requirements and modalities of this process remain elusive. Here we show that leukemic B cells from 14 of 20 CLLs contain the hallmarks of ongoing Ig class switch DNA recombination (CSR), including extrachromosomal switch circular DNAs and circle transcripts generated by direct S micro -->Sgamma, S micro -->Salpha, and S micro -->Sepsilon as well as sequential Sgamma-->Salpha and Sgamma-->Sepsilon CSR. Similar CLL B cells express transcripts for activation-induced cytidine deaminase, a critical component of the CSR machinery, and contain germline I(H)-C(H) and mature V(H)DJ(H)-C(H) transcripts encoded by multiple Cgamma, Calpha, and Cepsilon genes. Ongoing CSR occurs in only a fraction of the CLL clone, as only small proportions of CD5(+)CD19(+) cells express surface IgG or IgA and lack IgM and IgD. In vivo class-switching CLL B cells down-regulate switch circles and circle transcripts in vitro unless exposed to exogenous CD40 ligand and IL-4. In addition, CLL B cells that do not class switch in vivo activate the CSR machinery and secrete IgG, IgA, or IgE upon in vitro exposure to CD40 ligand and IL-4. These findings indicate that in CLL at least some members of the malignant clone actively differentiate in vivo along a pathway that induces CSR. They also suggest that this process is elicited by external stimuli, including CD40 ligand and IL-4, provided by bystander immune cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • B-Lymphocytes / drug effects
  • B-Lymphocytes / enzymology
  • B-Lymphocytes / immunology*
  • Base Sequence
  • CD40 Ligand / pharmacology
  • Cytidine Deaminase / metabolism
  • DNA, Circular / genetics
  • DNA, Neoplasm / genetics
  • Down-Regulation
  • Humans
  • Immunoglobulin A / biosynthesis
  • Immunoglobulin A / genetics
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin G / genetics
  • Immunoglobulin Switch Region*
  • In Vitro Techniques
  • Interleukin-4 / pharmacology
  • Leukemia, Lymphocytic, Chronic, B-Cell / enzymology
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Molecular Sequence Data
  • Phenotype
  • Recombinant Proteins / pharmacology
  • Recombination, Genetic*

Substances

  • DNA, Circular
  • DNA, Neoplasm
  • Immunoglobulin A
  • Immunoglobulin G
  • Recombinant Proteins
  • CD40 Ligand
  • Interleukin-4
  • AICDA (activation-induced cytidine deaminase)
  • Cytidine Deaminase